Following the voluntary Stryker hip recall of 2012, which pulled ABG II and Rejuvenate hip replacement systems off the market, thousands of affected patients sought legal recourse in an attempt to recover damages for pain, suffering, medical costs and lost income incurred. In the past... Read More

Dangerous and potentially defective medical devices continue to injure thousands of unsuspecting Americans each year. Faulty or poorly designed knee and hip replacements as well as transvaginal mesh implants have been tied to debilitating health problems, and spurred a wave of products liability litigation across... Read More

In a June 20 memorandum and ruling issued by the honorable Rebecca Doherty, the federal judge stated that ample evidence indicates that Takeda Pharmaceuticals, maker of Actos, has acted in bad faith during litigation by intentionally destroying key documents pertaining to bladder cancer risks. The... Read More

According to Harris Martin, Takeda is facing new legal action from Blue Cross and Blue Shield of Massachusetts Inc. The lawsuit is attempting to secure damages for claims paid out by the healthcare providers to patients who were diagnosed with bladder cancer after taking the... Read More

Throughout the nation, a growing number of men who took Low T supplements and later suffered adverse cardiovascular events are taking legal action against the drug manufacturers. Plaintiffs claim that products such as Androgel, Testim and Axiron – among others -- lacked sufficient warnings about... Read More

Since the DePuy ASR recall in 2010, a slew of product liability lawsuits alleging severe and permanent injuries have inundated the court system. To date, more than 12,000 plaintiffs have sued DePuy Orthopaedics after suffering catastrophic failure with the ASR XL Acetabular Hip – a... Read More

Federal health regulators in both the United States and Canada have released safety communications regarding power morcellation risks in laparoscopic hysterectomy procedures. On April 17, 2014, the FDA openly discouraged the use of laparoscopic power morcellation during hysterectomy or myomectomy for the treatment of uterine... Read More

In an FDA drug safety communication published on May 13, the agency warned of an increased stomach bleeding risk with Pradaxa compared to its competitor, warfarin. Both anticoagulant medications are used to reduce the chance of stroke in patients with non-valvular atrial fibrillation, but recent... Read More